Sunderland Joint Formulary
NHS Sunderland Clinical Commissioning Group
South Tyneside and Sunderland NHS Foundation Trust

 
back
10 Musculoskeletal and joint diseases
10-02 Drugs used in neuromuscular disorders

Nusinersen
Formulary

Nusinersen is recommended as an option for treating 5q spinal muscular atrophy (SMA) only if:

  • people have pre-symptomatic SMA, or SMA types 1, 2 or 3 and

  • the conditions in the managed access agreement are followed.

Link  NICE TA 588: Nusinersen for treating spinal muscular atrophy
 

Red View adult BNF  View SPC online
Mexiletine NaMuscla®
Formulary

Capsules: 167mg (NaMusclaź 167mg equivalent to 200mg mexiletine HCl) 

ONLY APPROVED FOR USE ON THE FORMULARY FOR THE FOLLOWING INDICATIONS. HOSPITAL ONLY DRUG FOR ALL INDICATIONS

* Myotonia in non-dystrophic myotonic disorders

* Neuropathic pain (unlicensed indication)

* Ventricular arrhythmia (unlicensed indication)

Red View adult BNF  View SPC online
Ataluren Translarna®
Non Formulary

View adult BNF  View SPC online